» Articles » PMID: 34504856

Case Report: Two Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccination

Overview
Specialty General Medicine
Date 2021 Sep 10
PMID 34504856
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Subacute thyroiditis is an inflammatory thyroid disorder associated with viral infections. Rare cases of subacute thyroiditis have also been described following vaccination. Recently, a few cases of subacute thyroiditis following SARS-CoV-2 vaccination have also been reported. Here, we present two cases of cytological proven subacute thyroiditis after receiving the first dose of a SARS-CoV-2 vaccination. We describe clinical, laboratory, imaging and cytological findings in two cases of subacute thyroiditis that presented in our department 2 weeks after SARS-CoV-2 vaccination with Spikevax (Moderna Biotech, Spain) and Vaxzevria (AstraZeneca; Sweden). Both cases did not have a previous history of thyroid disorders and presented with anterior and lateral neck pain. Clinical test results as well as cytological findings were consistent with subacute thyroiditis. Subacute thyroiditis may develop following a SARS-CoV-2 vaccination and should be considered as a possible side effect in cases that present with thyroid pain.

Citing Articles

SARS-CoV-2-Vaccine-Related Endocrine Disorders: An Updated Narrative Review.

Ishay A, Oleinikov K, Chertok Shacham E Vaccines (Basel). 2024; 12(7).

PMID: 39066388 PMC: 11281608. DOI: 10.3390/vaccines12070750.


Subacute thyroiditis after SARS-CoV-2 vaccination: A case report.

Akha O, Mazandarani M, Azari S, Daneshfar N, Rasouli K, Heydari K Clin Case Rep. 2024; 12(4):e8678.

PMID: 38550739 PMC: 10965450. DOI: 10.1002/ccr3.8678.


Case report: Neglected subacute thyroiditis: a case following COVID-19 vaccination.

Yang S, Guan T, Yang H, Hu Y, Zhao Y Front Med (Lausanne). 2024; 11:1349615.

PMID: 38523906 PMC: 10957742. DOI: 10.3389/fmed.2024.1349615.


Post-COVID-19 Vaccination and Thyrotoxicosis (ASIA Syndrome): Single-Centre Experience from India with Review of Literature.

Singhal V, Gupta S Indian J Endocrinol Metab. 2024; 27(6):524-529.

PMID: 38371178 PMC: 10871005. DOI: 10.4103/ijem.ijem_202_23.


Insights into SARS-CoV-2-associated subacute thyroiditis: from infection to vaccine.

Ziaka M, Exadaktylos A Virol J. 2023; 20(1):132.

PMID: 37344878 PMC: 10283227. DOI: 10.1186/s12985-023-02103-1.


References
1.
Hernan Martinez J, Corder E, Uzcategui M, Garcia M, Sostre S, Garcia A . Subacute thyroiditis and dyserythropoesis after influenza vaccination suggesting immune dysregulation. Bol Asoc Med P R. 2011; 103(2):48-52. View

2.
Altay F, Guz G, Altay M . Subacute thyroiditis following seasonal influenza vaccination. Hum Vaccin Immunother. 2016; 12(4):1033-4. PMC: 4962945. DOI: 10.1080/21645515.2015.1117716. View

3.
Rotondi M, Coperchini F, Ricci G, Denegri M, Croce L, Ngnitejeu S . Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis. J Endocrinol Invest. 2020; 44(5):1085-1090. PMC: 7538193. DOI: 10.1007/s40618-020-01436-w. View

4.
Passah A, Arora S, Damle N, Reddy K, Khandelwal D, Aggarwal S . Occurrence of Subacute Thyroiditis following Influenza Vaccination. Indian J Endocrinol Metab. 2018; 22(5):713-714. PMC: 6166570. DOI: 10.4103/ijem.IJEM_237_18. View

5.
Lazartigues E, Qadir M, Mauvais-Jarvis F . Endocrine Significance of SARS-CoV-2's Reliance on ACE2. Endocrinology. 2020; 161(9). PMC: 7454499. DOI: 10.1210/endocr/bqaa108. View